These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 26471036

  • 1. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK, Lam CL, Wan YF, Fong DY.
    BMC Cancer; 2015 Oct 15; 15():705. PubMed ID: 26471036
    [Abstract] [Full Text] [Related]

  • 2. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.
    Clin Gastroenterol Hepatol; 2013 Sep 15; 11(9):1158-66. PubMed ID: 23542330
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN, Ladabaum U.
    Am J Gastroenterol; 2013 Jan 15; 108(1):120-32. PubMed ID: 23247579
    [Abstract] [Full Text] [Related]

  • 4. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG, van Rijn AF, Verbeek AL, van Oijen MG, Laheij RJ, Fockens P, Jansen JB, Adang EM, Dekker E.
    Int J Cancer; 2011 Apr 15; 128(8):1908-17. PubMed ID: 20589677
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.
    Endoscopy; 2011 Sep 15; 43(9):780-93. PubMed ID: 21623557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J, Halloran S, Gray A.
    BMJ Open; 2017 Oct 27; 7(10):e017186. PubMed ID: 29079605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fecal occult blood testing when colonoscopy capacity is limited.
    Wilschut JA, Habbema JD, van Leerdam ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ, van Ballegooijen M.
    J Natl Cancer Inst; 2011 Dec 07; 103(23):1741-51. PubMed ID: 22076285
    [Abstract] [Full Text] [Related]

  • 15. Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.
    Lee KS, Park EC.
    Cancer Res Treat; 2016 Jul 07; 48(3):1010-9. PubMed ID: 26727714
    [Abstract] [Full Text] [Related]

  • 16. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
    Engel-Nitz NM, Miller-Wilson LA, Le L, Fisher DA.
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jul 07; 23(7):843-852. PubMed ID: 37462667
    [Abstract] [Full Text] [Related]

  • 17. Análisis de Costo-Efectividad de las Estrategias de Tamización de Cáncer Colorrectal en Colombia.
    Pinzon Florez CE, Rosselli D, Gamboa Garay OA.
    Value Health Reg Issues; 2012 Dec 07; 1(2):190-200. PubMed ID: 29702900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.